Evidence map›Paper›PMID 20214779›Full record

ArticleCritical care (London, England)2010

Preadmission statin use and one-year mortality among patients in intensive care - a cohort study.

Steffen Christensen, Reimar W Thomsen, Martin B Johansen, Lars Pedersen, Reinhold Jensen, Kim M Larsen, Anders Larsson, Else Tønnesen, Henrik Toft Sørensen

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. The Danish Intensive Care Database.Clinical epidemiology · 2016
    Review
  10. Article
  11. Review
  12. Article
  13. Statins in the critically ill.Annals of intensive care · 2012
    Article
  14. Article
  15. Article
  16. The immune response: targets for the treatment of severe sepsis.International journal of inflammation · 2012
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Steffen ChristensenDepartment of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes alle 43-45, Arhus N, Denmark. steffchris@hotmail.com
Reimar W Thomsen
Martin B Johansen
Lars Pedersen
Reinhold Jensen
Kim M Larsen
Anders Larsson
Else Tønnesen
Henrik Toft Sørensen
Aarhus University Hospital · DKAalborg University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionStatins reduce risk of cardiovascular events and have beneficial pleiotropic effects; both may reduce mortality in critically ill patients. We examined whether statin use was associated with risk of death in general intensive care unit (ICU) patients.

methodsCohort study of 12,483 critically ill patients > 45 yrs of age with a first-time admission to one of three highly specialized ICUs within the Aarhus University Hospital network, Denmark, between 2001 and 2007. Statin users were identified through population-based prescription databases. We computed cumulative mortality rates 0-30 days and 31-365 days after ICU admission and mortality rate ratios (MRRs), using Cox regression analysis controlling for potential confounding factors (demographics, use of other cardiovascular drugs, comorbidity, markers of social status, diagnosis, and surgery).

results1882 (14.3%) ICU patients were current statin users. Statin users had a reduced risk of death within 30 days of ICU admission [users: 22.1% vs. non-users 25.0%; adjusted MRR = 0.76 (95% confidence interval (CI): 0.69 to 0.86)]. Statin users also had a reduced risk of death within one year after admission to the ICU [users: 36.4% vs. non-users 39.9%; adjusted MRR = 0.79 (95% CI: 0.73 to 0.86)]. Reduced risk of death associated with current statin use remained robust in various subanalyses and in an analysis using propensity score matching. Former use of statins and current use of non-statin lipid-lowering drugs were not associated with reduced risk of death.

conclusionsPreadmission statin use was associated with reduced risk of death following intensive care. The associations seen could be a pharmacological effect of statins, but unmeasured differences in characteristics of statin users and non-users cannot be entirely ruled out.

Indexed as

Intensive Care UnitsAgedCohort StudiesCritical IllnessDenmarkFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedMortalityPatient AdmissionProportional Hazards ModelsRisk AssessmentHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID20214779
PMCPMC2887131
OpenAlexW2109609210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.